Visalytics
Visalytics
approved EB-2 (NIW)

Senior Biostatistician

Biostatistics · China · 2023-07-18

Processing Time
8 days
Decision Date
2023-07-18
Location
Georgia
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance statistical models for drug development and clinical trial methodologies to improve cancer prognosis and treatment outcomes. His work focuses on time-to-event data analysis to enhance the accurate prediction of patient outcomes, risk stratification, and the optimization of clinical trial designs within the pharmaceutical industry.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses critical challenges in public health, including cancer treatment strategies and clinical trial optimization.

2 Well Positioned to Advance the Endeavor Met

The petitioner holds a Ph.D. in biostatistics and has a proven track record in both academia and the pharmaceutical industry.

3 Balance of Factors Met

On balance, the petitioner’s contributions to oncology research and drug development justify a waiver of the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 8 peer-reviewed journal articles and 220 citations, indicating significant influence in the field. He also demonstrated expertise through 20 peer reviews and research support from the National Institutes of Health (NIH). The case satisfied all three Dhanasar prongs, supported by four expert recommendation letters.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Reference Letters Independent
Reference Letters Dependent
Judging Experience
Government Alignment

Similar Cases

Statistician

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
New Jersey 50 days 2025-03-09
The petitioner proposes to enhance the design and analysis of clinical trials through advanced statistical methodologies and machine learning. His work focuses on creating innovative tools that optimize clinical trial accuracy and accelerate therapeutic approvals for oncology, cardiovascular diseases, and infectious diseases. This endeavor aims to improve public health outcomes by ensuring regulatory compliance and addressing safety evaluation challenges in complex medical conditions.
View Case

Research Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
New Jersey 367 days 2022-04-05
The petitioner proposes to develop and apply novel statistical methodologies to more accurately evaluate healthcare data and improve treatment efficacy. Her work focuses on characterizing the mechanisms for conditions such as cancer and COVID-19 to improve global treatment strategies.
View Case

Clinical Researcher

Healthcare · Vietnam

WeGreened EB-2 (NIW) rfe approved
139 days 2025-04-24
The petitioner proposes to advance personalized oncology by integrating multi-omics analysis for biomarker discovery and population pharmacokinetic modeling to optimize cancer therapy. His work focuses on implementing model-informed precision dosing strategies and translating these innovations into real-world clinical settings to improve patient-centered therapeutic interventions.
View Case

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Pharmaceuticals cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-07-18.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 8 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist